This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Products


Aldurazyme® (laronidase)
Aldurazyme®
Lantus® (insulin glargine 100 units/mL)
Lantus®
Lemtrada® (alemtuzumab)
Lemtrada®
GB only content
MenQuadfiTM▼  (meningococcal (group A,C,W,Y) conjugate vaccine)
MenQuadfiTM▼ 
Nexviadyme Logo
Nexviadyme®
Quadrivalent Influenza Vaccine (split virion, inactivated)
Quadrivalent Influenza Vaccine
GB only content
Supemtek▼ (quadrivalent Influenza Vaccine (recombinant, prepared in cell culture))
Supemtek▼
GB only content
Vaxelis®
Viatim®

MAT-XU-2305047 (v1.0) Date of preparation: November 2023